Comparative analysis of tumor angiogenesis and clinical features of 55 cases of pleomorphic carcinoma and adenocarcinoma of the lung

Anticancer Res. 2015 Jan;35(1):389-94.

Abstract

Background/aim: Pleomorphic carcinoma (PC) of the lung is a rare tumor that usually has an aggressive clinical course and a poor prognosis. Clinical and pathological features remain unclear. The aim of this study was to determine whether tumor angiogenesis of PC is up-regulated compared to that in adenocarcinoma (AD).

Materials and methods: We collected 55 cases of PC and AD in which the patients had undergone either lung resection or autopsy and immunohistochemically examined the expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor (HIF)-1α and microvessel density (MVD) in tissue specimens.

Results: VEGF was expressed in many cases of both PC and AD with no significant differences between the groups. In contrast, the expression of HIF-1α and MVD were significantly greater in PC than AD. Median survival time of the PC group was 14.7 months and significantly shorter than that of the AD group.

Conclusion: MVD and expression of HIF-1α are associated with angiogenesis in PC and confer a poorer prognosis. Tumor angiogenesis provides significant prognostic information regarding clinical outcome in patients with PC.

Keywords: Pleomorphic carcinoma; angiogenesis; hypoxia-inducible factor-1α; immunohistochemistry; vascular endothelial growth factor.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma / blood supply*
  • Adenocarcinoma / metabolism
  • Adenocarcinoma / mortality
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiogenic Proteins / metabolism
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Lung Neoplasms / blood supply*
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / mortality
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neovascularization, Pathologic / metabolism*
  • Neovascularization, Pathologic / mortality
  • Prognosis
  • Proportional Hazards Models

Substances

  • Angiogenic Proteins